Intracranial Atherosclerosis: Current Understanding and Perspectives

키워드

참고문헌 (78)

1. Amarenco P., "High-dose atorvastatin after stroke or transient ischemic attack", N Engl J Med, 355, pp.549~559 (2006)
2. Furie KL., "Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack : a guideline for healthcare professionals from the american heart association", american stroke association, 2011, pp.42, 227~276
3. Lee PH., "Infarct patterns in atherosclerotic middle cerebral artery versus internal carotid artery disease", Neurology, 62, pp.1291~1296 (2004)
4. Shin DH., "Mechanisms of recurrence in subtypes of ischemic stroke : a hospital-based follow-up study", Arch Neurol, 62, pp.1232~1237 (2005)
5. Bang OY., "Inflammatory markers, rather than conventional risk factors, are different between carotid and mca atherosclerosis", J Neurol Neurosurg Psychiatry, 76, pp.1128~1134 (2005)
6. Chimowitz MI., "Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis", N Engl J Med, 352, pp.1305~1316 (2005)
7. Chimowitz MI., "Stenting versus aggressive medical therapy for intracranial arterial stenosis", N Engl J Med, 365, pp.993~1003 (2011)
8. Qureshi AI., "Intracranial atherosclerotic disease : an update", Ann Neurol, 66, pp.730~738 (2009)
9. Bos D., "Intracranial carotid artery atherosclerosis : prevalence and risk factors in the general population", Stroke, 43, pp.1878~1884 (2012)
10. Wong KS., "Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients", Neurology, 68, pp.2035~2038 (2007)
11. Wong LK., "Global burden of intracranial atherosclerosis", Int J Stroke, 1, pp.158~159 (2006)
12. Sacco RL., "Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction : the Northern Manhattan Stroke Study", Neurology, 45, pp.659~663 (1995)
13. Gorelick PB., "Large artery intracranial occlusive disease : a large worldwide burden but a relatively neglected frontier", Stroke, 39, pp.2396~2399 (2008)
14. Mak W., "A possible explanation for the racial difference in distribution of large-arterial cerebrovascular disease : ancestral european settlers evolved genetic resistance to atherosclerosis, but confined to the intracranial arteries", Medical Hypotheses, 65, pp.637~648 (2005)
15. Sacco RL., "Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study", Stroke, 26, pp.14~20 (1995)
16. Forouhi NG., "Cvd risk factors and ethnicity--a homogeneous relationship?", Atheroscler Suppl, 7, pp.11~19 (2006)
17. Boden-Albala B., "Metabolic syndrome and ischemic stroke risk : Northern Manhattan Study", Stroke, 39, pp.30~35 (2008)
18. Bang OY., "Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis : data from a diverse race-ethnic group", J Neurol Sci, 284, pp.40~45 (2009)
19. Hachinski V., "Stroke in Korean", Stroke, 39, pp.1067~ (2008)
20. Jung KH., "Secular trends in ischemic stroke characteristics in a rapidly developed country : results from the Korean Stroke Registry Study(secular trends in Korean stroke)", Circ Cardiovasc Qual Outcomes, 5, pp.327~334 (2012)
21. Kamada F., "A genome-wide association study identifies RNF213 as the first Moyamoya disease gene", J Hum Genet, 56, pp.34~40 (2011)
22. Liu W., "Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development", PLoS One, 6, pp.e22542~ (2011)
23. Liu W., "A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians", Environ Health Prev Med, 15, pp.94~104 (2010)
24. Liu W., "Distribution of Moyamoya disease susceptibility polymorphism p. R4810K in RNF213 in East and Southeast Asian populations", Neurol Med Chir, 52, pp.299~303 (2012)
25. Sang Hyuk Yim, "Prevalence and Epidemiological Features of Moyamoya Disease in Korea", Journal of Cerebrovascular and Endovascular Neurosurgery, 14(2), pp.75~78 (2012), 대한뇌혈관외과학회
26. Mazighi M., "Prospective study of symptomatic atherothrombotic intracranial stenoses : the GESICA study", Neurology, 66, pp.1187~1191 (2006)
27. Kasner SE., "Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis", Circulation, 113, pp.555~563 (2006)
28. Arenillas JF., "Progression and clinical recurrence of symptomatic middle cerebral artery stenosis : a longterm follow-up transcranial Doppler ultrasound study", Stroke, 32, pp.2898~2904 (2001)
29. Wong KS., "Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke", Stroke, 33, pp.532~536 (2002)
30. Jung JM., "Predictors of recurrent stroke in patients with symptomatic intracranial arterial stenosis", Stroke, 43, pp.2785~2787 (2012)
31. Wong KS., "Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis : a diffusion-weighted imaging and microemboli monitoring study", Ann Neurol, 52, pp.74~81 (2002)
32. Bang OY., "Middle cerebral artery stenosis is a major clinical determinant in striatocapsular small, deep infarction", Arch Neurol, 59, pp.259~263 (2002)
33. Ryoo S., "Branch occlusive disease : clinical and magnetic resonance angiography findings", Neurology, 78, pp.888~896 (2012)
34. Nah HW., "Diversity of single small subcortical infarctions according to infarct location and parent artery disease : analysis of indicators for small vessel disease and atherosclerosis", Stroke, 41, pp.2822~2827 (2010)
35. Gomez CR., "Medical treatment of patients with intracranial atherosclerotic disease", J Neuroimaging, 19(Suppl 1), pp.25S~29S (2009)
36. Mazighi M., "Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke", Stroke, 39, pp.1142~1147 (2008)
37. Xu WH., "In vivo highresolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis", Atherosclerosis, 212, pp.507~511 (2010)
38. Skarpathiotakis M., "Intracranial atherosclerotic plaque enhancement in patients with ischemic stroke", AJNR Am J Neuroradiol, 34, pp.299~304 (2013)
39. Kim JM., "Middle cerebral artery plaque and prediction of the infarction pattern", Arch Neurol, 69, pp.1470~1475 (2012)
40. Xu WH., "Plaque distribution of stenotic middle cerebral artery and its clinical relevance", Stroke, 42, pp.2957~2959 (2011)
41. Yoon Y., "Single subcortical infarction and atherosclerotic plaques in the middle cerebral artery : high-resolution magnetic resonance imaging findings", Stroke, 44, pp.2462~2467 (2013)
42. Wong KS., "Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in asian patients with large artery occlusive disease : a randomised study", Lancet Neurol, 6, pp.407~413 (2007)
43. Whiteley WN., "Targeted use of heparin, heparinoids, or lowmolecular-weight heparin to improve outcome after acute ischaemic stroke : an individual patient data meta-analysis of randomised controlled trials", Lancet Neurol, 12, pp.539~545 (2013)
44. Turan TN., "Treatment of atherosclerotic intracranial arterial stenosis", Stroke, 40, pp.2257~2261 (2009)
45. Abou-Chebl A., "Critique of"Stenting versus aggressive medical therapy for intracranial arterial stenosis"by Chimowitz et al in the new England Journal of Medicine", Stroke, 43, pp.616~620 (2012)
46. Marks MP., "Is there a future for endovascular treatment of intracranial atherosclerotic disease after stenting and aggressive medical management for preventing recurrent stroke and intracranial stenosis(SAMMPRIS)?", Stroke, 43, pp.580~584 (2012)
47. Marquardt L., "Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, populationbased study", Stroke, 41, pp.e11~e17 (2010)
48. Bang OY., "Association of the metabolic syndrome with intracranial atherosclerotic stroke", Neurology, 65, pp.296~298 (2005)
49. Park JH., "Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis", Eur J Neurol, 14, pp.379~386 (2007)
50. Kim YD., "Classic risk factors for atherosclerosis are not major determinants for location of extracranial or intracranial cerebral atherosclerosis", Neuroepidemiology, 32, pp.201~207 (2009)
51. Bang OY., "Adiponectin levels in patients with intracranial atherosclerosis", Neurology, 68, pp.1931~1937 (2007)
52. Rincon F., "Incidence and risk factors of intracranial atherosclerotic stroke : the Northern Manhattan Stroke Study", Cerebrovasc Dis, 28, pp.65~71 (2009)
53. Lopez-Cancio E., "Biological signatures of asymptomatic extra-and intracranial atherosclerosis : the Barcelona-Asia(Asymptomatic Intracranial Atherosclerosis)study", Stroke, 43, pp.2712~2719 (2012)
54. Turan TN., "Risk factors associated with severity and location of intracranial arterial stenosis", Stroke, 41, pp.1636~1640 (2010)
55. Yamada Y., "Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome", Int J Mol Med, 21, pp.801~808 (2008)
56. Bang OY., "Intracranial atherosclerotic stroke : specific focus on the metabolic syndrome and inflammation", Curr Atheroscler Rep, 8, pp.330~336 (2006)
57. Anderson TJ., "Assessment and treatment of endothelial dysfunction in humans", J Am Coll Cardiol, 34, pp.631~638 (1999)
58. Jung KH., "Circulating endothelial microparticles as a marker of cerebrovascular disease", Ann Neurol, 66, pp.191~199 (2009)
59. Ratchford EV., "Short-term effect of atorvastatin on carotid artery elasticity : a pilot study", Stroke, 42, pp.3460~3464 (2011)
60. Oyama N., "Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats", Stroke, 42, pp.2571~2577 (2011)
61. Kwon SU., "Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis : the multicenter double-blind placebocontrolled trial of cilostazol in symptomatic intracranial arterial stenosis", Stroke, 36, pp.782~786 (2005)
62. Kwon SU., "Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis", Stroke, 42, pp.2883~2890 (2011)
63. Wong KS., "Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis(CLAIR study) : a randomised, open-label, blinded-endpoint trial", Lancet Neurol, 9, pp.489~497 (2010)
64. Pu Y., "Geographic and sex difference in the distribution of intracranial atherosclerosis in china", Stroke, 44, pp.2109~2114 (2013)
65. Khan M., "Intracranial atherosclerotic disease", Stroke Res Treat, 2011, pp.282845~ (2011)
66. Wong KS., "A door-to-door survey of intracranial atherosclerosis in Liangbei County, China", Neurology, 68, pp.2031~2034 (2007)
67. Huang HW., "Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong", Cerebrovasc Dis, 24, pp.111~115 (2007)
68. Bae HJ., "Risk factors of intracranial cerebral atherosclerosis among asymptomatics", Cerebrovasc Dis, 24, pp.355~360 (2007)
69. Moossy J., "Pathology of cerebral atherosclerosis. Influence of age, race, and gender", Stroke, 24, pp.I22-23~I31-22 (1993)
70. Park KY., "Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic Korean population", J Clin Neurol, 2, pp.29~33 (2006)
71. Uehara T., "Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese", Eur J Neurol, 12, pp.218~222 (2005)
72. Kim DE., "Associations of cigarette smoking with intracranial atherosclerosis in the patients with acute ischemic stroke", Clin Neurol Neurosurg, 114, pp.1243~1247 (2012)
73. Miyazawa N., "Analysis of incidence and risk factors for progression in patients with intracranial steno-occlusive lesions by serial magnetic resonance angiography", Clin Neurol Neurosurg, 109, pp.680~685 (2007)
74. Akins PT., "Natural history of stenosis from intracranial atherosclerosis by serial angi-ography", Stroke, 29, pp.433~438 (1998)
75. Chaturvedi S., "Risk factor status and vascular events in patients with symptomatic intracranial stenosis", Neurology, 69, pp.2063~2068 (2007)
76. Ovbiagele B., "Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis", Neurology, 66, pp.1344~1349 (2006)
77. Waddy SP., "Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis", Stroke, 40, pp.719~725 (2009)
78. Liebeskind DS., "Collaterals dramatically alter stroke risk in intracranial atherosclerosis", Ann Neurol, 69, pp.963~974 (2011)

관련 논문AI추천